Accolade, Inc. - common stock (NQ:ACCD)

7.020 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Accolade, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

MarketBeat Week in Review – 7/10 - 7/14

July 15, 2023

As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week

Via MarketBeat

Topics Economy

Accolade: A Rising Personalized AI-Powered Healthcare Platform

July 11, 2023

Accolade Inc. (NASDAQ: ACCD) provides an artificial intelligence (AI)-powered healthcare platform. Learn more about Accolade Inc. stock.

Via MarketBeat

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 05, 2023

Via Benzinga

Why Accolade Stock Popped by Almost 7% Today ↗

June 30, 2023

A double beat and raised guidance bring the bulls roaring back to the stock.

Via The Motley Fool

Accolade: Q1 Earnings Insights ↗

June 29, 2023

Via Benzinga

Earnings Outlook For Accolade ↗

June 28, 2023

Via Benzinga

What 12 Analyst Ratings Have To Say About Accolade ↗

June 22, 2023

Via Benzinga

Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 05, 2023

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...

Via Benzinga

Accolade's Pipeline Strength Amid Solid Demand To Propel Growth, Bullish Analyst Says ↗

June 30, 2023

Needham analyst Ryan MacDonald reiterated a Buy rating on the shares of Accolade, Inc. (NASDAQ: ACCD),

Via Benzinga

Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 30, 2023

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...

Via Benzinga

What 12 Analyst Ratings Have To Say About Accolade ↗

May 24, 2023

Via Benzinga

Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday ↗

June 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Analyst Says Accolade's Q1 Earning, Annual Guidance Reflect Solid Performance Amid Uncertain Macroeconomic Environment ↗

June 30, 2023

Accolade Inc (NASDAQ: ACCD) posted Q1 FY24 sales of $93.2 million, up 9% Y/Y, beating the

Via Benzinga

Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket ↗

June 30, 2023

Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.

Via Benzinga

NVIDIA To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Friday ↗

June 30, 2023

Truist Securities boosted the price target for BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from $125 to $140. Truist Securities analyst Robyn Karnauskas maintained a Buy rating. BioMarin Pharmaceutical...

Via Benzinga

Accolade Earnings Perspective: Return On Capital Employed ↗

May 03, 2023

Via Benzinga

A Preview Of Accolade's Earnings ↗

April 26, 2023

Via Benzinga

Analyst Ratings for Accolade ↗

April 21, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 30, 2023

It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!

Via InvestorPlace

Shareholders Like What These 2 Companies Just Told Them ↗

June 29, 2023

Good financial results have investors feeling bullish about their prospects.

Via The Motley Fool

Accolade Announces Results for Fiscal First Quarter 2024

June 29, 2023

From Accolade, Inc.

Via GlobeNewswire

Accolade's Financial Forecast: Anticipating Raised Guidance and Robust Revenue Growth ↗

June 26, 2023

Needham analyst Ryan MacDonald reiterated a Buy rating on the shares of Accolade, Inc. (NASDAQ: ACCD) with a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023 ↗

May 24, 2023

Via Benzinga

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May ↗

May 11, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023

April 27, 2023

From Accolade, Inc.

Via GlobeNewswire

Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 28, 2023

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.

Via Benzinga

Accolade Inc. (NASDAQ: ACCD) Records 52-Week High Thursday Morning

April 27, 2023

Via Investor Brand Network

Humana Stock Checkup Shows Healthy Growth; Profits Strong ↗

April 25, 2023

Among its other ratings, Louisville, Ky.-based Humana boasts a 94 EPS Rating, out of 99, showing strong profit growth. Humana stock rose.

Via Investor's Business Daily

Barrick Gold To Rally Over 47%? Here Are 10 Other Analyst Forecasts For Friday ↗

April 21, 2023

Keybanc raised the price target for Watsco, Inc. (NYSE: WSO) from $365 to $380. Keybanc analyst Jeffrey Hammond maintained an Overweight rating. Watsco shares gained 8.3% to close at $342.93 on...

Via Benzinga

Accolade Inc. (NASDAQ: ACCD) Records 52-Week High Wednesday Morning

April 12, 2023

Via Investor Brand Network

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.